反応式
Cl[C:2]1[N:7]=[CH:6][C:5]([O:8][CH:9]2[CH2:12][N:11]([C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])[CH2:10]2)=[CH:4][CH:3]=1.[CH3:20][S:21]([C:24]1[CH:25]=[C:26]2[C:30](=[CH:31][CH:32]=1)[NH:29][CH:28]=[CH:27]2)(=[O:23])=[O:22]>>[C:16]([O:15][C:13]([N:11]1[CH2:12][CH:9]([O:8][C:5]2[CH:6]=[N:7][C:2]([N:29]3[C:30]4[C:26](=[CH:25][C:24]([S:21]([CH3:20])(=[O:23])=[O:22])=[CH:32][CH:31]=4)[CH:27]=[CH:28]3)=[CH:3][CH:4]=2)[CH2:10]1)=[O:14])([CH3:19])([CH3:18])[CH3:17]参加物
3
実験手順
The title compound was prepared by following the similar procedure as described in Example-1 by using tert-butyl 3-((6-chloropyridin-3-yl)oxy)azetidine-1-carboxylate (intermediate-9) and 5-(methylsulfonyl)-1H-indole (intermediate-21).
出典と根拠
- ORDレコード
- ord-256eb04dc97d4e1fab68fb17b38855dd
- 出典データセット
- uspto-grants-2015_04
- 特許番号
- US09000175B2
関連ノート
読み込み中…